Literature DB >> 16421725

The receptor for erythropoietin is present on cutaneous mast cells.

Rieko Isogai1, Masae Takahashi, Kinuyo Aisu, Yoshitaka Horiuti, Yoshinori Aragane, Akira Kawada, Tadashi Tezuka.   

Abstract

Skin samples from patients with extra-mammary Paget disease, Bowen's disease, atopic dermatitis, psoriasis and non-lesional skin of nevus pigmentosus were immunohistochemically examined with an anti-soluble erythropoietin receptor antibody (anti-sEPOR antibody), and only the dermal mast cells positively stained in all skin samples were examined. These positively stained dermal cells were proved to be mast cells by double staining with anti-sEPOR antibody and either with anti-bikunin antibody or anti-tryptase antibody. Immunoelectron microscopically these EPOR were found in the secretory granules of the dermal mast cells. Further, EPOR in the mast cells may be consisting of only the extracellular domain of erythropoietin receptor molecule as the mast cells were immunohistochemically not reacted with an antibody to the C-terminal peptide of EPOR. Human mast cell line, HMC-1 cells has immunohistochemically the erythropoietin receptor, which was consisting of a 43 kDa major protein and a 20 kDa minor protein in the immunoelectrophoresis. These data may indicate that EPOR in the mast cells may not be the whole molecule, but probably the soluble one of EPOR.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16421725     DOI: 10.1007/s00403-005-0615-3

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  7 in total

1.  Erythropoietin-driven proliferation of cells with mutations in the tumor suppressor gene TSC2.

Authors:  Yoshihiko Ikeda; Angelo M Taveira-DaSilva; Gustavo Pacheco-Rodriguez; Wendy K Steagall; Souheil El-Chemaly; Bernadette R Gochuico; Rose M May; Olanda M Hathaway; Shaowei Li; Ji-an Wang; Thomas N Darling; Mario Stylianou; Joel Moss
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-10-29       Impact factor: 5.464

2.  Erythropoietin is involved in angiogenesis in human primary melanoma.

Authors:  Domenico Ribatti; Beatrice Nico; Maria Teresa Perra; Vito Longo; Cristina Maxia; Tiziana Annese; Franca Piras; Daniela Murtas; Paola Sirigu
Journal:  Int J Exp Pathol       Date:  2010-08-27       Impact factor: 1.925

3.  Mast cells and macrophages in duodenal mucosa of mice overexpressing erythropoietin.

Authors:  Domenico Ribatti; Enrico Crivellato; Beatrice Nico; Diego Guidolin; Max Gassmann; Valentin Djonov
Journal:  J Anat       Date:  2009-08-18       Impact factor: 2.610

4.  Impaired synthesis of erythropoietin, glutamine synthetase and metallothionein in the skin of NOD/SCID/gamma(c)(null) and Foxn1 nu/nu mice with misbalanced production of MHC class II complex.

Authors:  L Danielyan; S Verleysdonk; M Buadze; C H Gleiter; G H Buniatian
Journal:  Neurochem Res       Date:  2009-10-14       Impact factor: 3.996

Review 5.  Erythropoietin and its derivatives: from tissue protection to immune regulation.

Authors:  Bo Peng; Gangcheng Kong; Cheng Yang; Yingzi Ming
Journal:  Cell Death Dis       Date:  2020-02-03       Impact factor: 8.469

6.  Evaluation of topical erythropoietin application on the healing outcome of gingival graft recipient site; a randomized controlled clinical trial.

Authors:  Siamak Yaghobee; Nina Rouzmeh; Mina Taheri; Hoori Aslroosta; Sanaz Mahmoodi; Masoomeh Mohammadnejad Hardoroodi; Pardis Soleimanzadeh Azar; Afshin Khorsand
Journal:  BMC Oral Health       Date:  2021-11-12       Impact factor: 2.757

Review 7.  Locally Applied Repositioned Hormones for Oral Bone and Periodontal Tissue Engineering: A Narrative Review.

Authors:  Gamal Abdel Nasser Atia; Hany K Shalaby; Mehrukh Zehravi; Mohamed Mohamady Ghobashy; Zubair Ahmad; Farhat S Khan; Abhijit Dey; Md Habibur Rahman; Sang Woo Joo; Hasi Rani Barai; Simona Cavalu
Journal:  Polymers (Basel)       Date:  2022-07-21       Impact factor: 4.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.